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Abstract
Background and Aims: Hereditary disorders associated with metal overload or unwanted toxic accumulation of heavy
metals can lead to morbidity and mortality. Patients with hereditary hemochromatosis or Wilson disease for example may
develop severe hepatic pathology including fibrosis, cirrhosis or hepatocellular carcinoma. While relevant disease genes are
identified and genetic testing is applicable, liver biopsy in combination with metal detecting techniques such as energy-
dispersive X-ray spectroscopy (EDX) is still applied for accurate diagnosis of metals. Vice versa, several metals are needed in
trace amounts for carrying out vital functions and their deficiency due to rapid growth, pregnancy, excessive blood loss, and
insufficient nutritional or digestive uptake results in organic and systemic shortcomings. Established in situ techniques, such
as EDX-ray spectroscopy, are not sensitive enough to analyze trace metal distribution and the quantification of metal
images is difficult.
Methods: In this study, we developed a quantitative biometal imaging technique of human liver tissue by laser ablation
inductively coupled plasma mass spectrometry (LA-ICP-MS) in order to compare the distribution of selected metals in cryo-
sections of healthy and fibrotic/cirrhotic livers.
Results: Most of the metals are homogeneous distributed within the normal tissue, while they are redirected within fibrotic
livers resulting in significant metal deposits. Moreover, total iron and copper concentrations in diseased liver were found
about 3-5 times higher than in normal liver samples.
Conclusions: Biometal imaging via LA-ICP-MS is a sensitive innovative diagnostic tool that will impact clinical practice in
identification and evaluation of hepatic metal disorders and to detect subtle metal variations during ongoing hepatic
fibrogenesis.
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Introduction
Hepatic fibrosis, cirrhosis and hepatocellular carcinoma are
characterized by a drastic increase of extracellular matrix proteins
comprising collagens, glycoproteins, proteoglycans and hyalur-
onan [1,2]. The pathogenesis is triggered by various noxious
agents (e.g. alcohol, drugs, viruses, and parasites), cholestasis,
autoimmune reactions, metabolic diseases, or other exogenous or
endogenous stimuli [1,2]. In addition, the overload with metals or
trace elements that originates from hereditary disorders, nutri-
tional oversupply, or occupational exposure is potentially causative
for the pathogenesis of liver diseases. Hereditary hemochromatosis
for example is the most common inherited disease of iron
metabolism that results in toxic accumulation of iron in
parenchymal cells of the liver [3]. This disease is most often
associated with a polymorphism within the HFE gene that is quite
common among white people resulting in an amino acid exchange
(i.e. C282Y). Homozygous carriers usually have increased serum
transferrin saturation levels and increased serum ferritin levels. In
addition, non-HFE hepatic iron overload diseases originate from
mutation in other genes such as transferin receptor 2, hepcidin,
hemojuvelin, and ferroportin [4]. Since these genes influence net
iron concentration by affecting the synthesis and activity of the
peptide hormone hepcidin that represents the master regulator of
iron homeostasis, respective mutational alterations most often give
rise to elevated concentrations of circulating iron and thus
overload occurs. Conversely, iron deficiency resulting from
decreased iron uptake, low absorption, rapid growth, pregnancy,
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and blood loss provoked by frequent blood donation or heavy
menstrual periods, leads to anemia impairing proper body
function.
Copper is a unique essential trace element playing an important
function as a cofactor for a number of cellular processes [5].
Copper homeostasis is regulated by copper uptake in the
gastrointestinal tract, distribution through the body, and excretion
mainly into the bile. At the cellular level two copper transporters
namely CTR1 and CTR2 regulate the intake, while copper efflux
occurs via the ATP-dependent pumps ATP7B and ATP7A [6].
Hepatic copper accumulation can result from increased copper
intake, inherited metabolic defects or from a reduced biliary
excretion of copper. Wilson disease (WD) is an autosomal recessive
disease caused by mutations of the WD gene ATP7B resulting in
copper accumulation in different tissues. In liver, ATP7B is mainly
expressed in hepatocytes and its loss is the basis for reduced
hepatic biliary copper excretion and reduced incorporation of
copper into ceruloplasmin [7]. Affected patients display hepatic
and neurological disease with yet poorly understood pathome-
chanisms. In line, Atp7b-/- mutant mice display a gradual
accumulation of hepatic copper inducing gross anatomic liver
abnormalities in older mice with an irregular liver surface with
protruding regenerative nodules of different sizes indicative for
cirrhosis [8].
These examples underline that body metal homeostasis is
crucial and metal deficiencies or dramatic build-ups should be
prevented to avoid hepatic or other organic impairments.
Therefore, indicative, non-invasive serum parameters (e.g. serum
transferrin concentration and saturation, ferritin, haemoglobin,
hematocrit, serum ceruloplasmin) and genetic testing of causative
genes is widely propagated in diagnosis to identify metal disorders
or predisposition for respective diseases. Moreover, the perfor-
mance of liver biopsy to measure or stain in situ metal content in
combination with scanning electron microscopy with energy-
dispersive X-ray analysis (SEM-EDX) is traditionally the confir-
matory test in cases in which the non-invasive markers suggest
elevated metal concentrations. Unfortunately SEM-EDX is often
not sensitive enough for trace element imaging. However, liver
heterogeneity can result in wrong analytical data). Therefore,
novel imaging techniques that provide information about the
regional distribution of individual metals or groups of metals
combined with a diagnostic score system further providing
information about the extent of hepatic insult are urgent required.
Although potentially not causative, the outcome of hepatic
fibrosis is also significantly modulated by variations in hepatic
metal distribution and concentrations. Hepatic iron overload for
example has been described in chronic hepatitis C as a cofactor
affecting fibrosis progression and hepatic iron deposits were found
in well-compensated chronic hepatitis B infection, especially in
patients that were co-infected with hepatitis D virus [9]. Likewise,
severe copper deficiency exacerbates liver injury and liver fibrosis
in rats that underwent experimental bile duct ligation surgery [10],
again demonstrating that variations in individual metal concen-
trations might not only be the result of ongoing hepatic
fibrogenesis but are further important modulators in disease
progression. Therefore, there is no doubt that accurate method
allowing to measure hepatic metal concentrations or to detect
metals deposits are of important diagnostic relevance not only in
determination liver insult but further to predict overall disease
outcome.
Magnetic resonance imaging (MRI) allows the mapping only of
selected single metals (such as iron) in organs [11], but the
quantification is often difficult [12]. Novadays, laser ablation
inductively coupled plasma mass spectrometry (LA-ICP-MS)
techniques with multi-element capability and high spatial resolu-
tion are herein discussed has been established to a new generation
of sensitive analytical tools for imaging of metals in biological
tissue.
Recently, LA-ICP-MS imaging technique has been applied as a
reference standard method to validate the results from quantitative
gadolinium enhanced MRI technique [12]. Although LA-ICP-MS
imaging has been introduced in diagnosis of metal disorders in
brain [13–16], this innovative technique has not been used in
quantitative bioimaging of metals in human liver. A first report
from Feldmann’s working group from 2003 demonstrated for
copper and zinc in sheep liver sections the capability of LA-ICP-
MS for elemental mapping [17]. In another previous study, LA-
ICP-MS imaging revealed that staphylococcal aureus liver abscesses
from normal mice are enriched in Ca2+, while these abscesses are
devoid of detectable Zn2+ and Mn2+ [18]. These studies are
encouraging and show that LA-ICP-MS is indeed a methodology
that might be suitable to detect delicate metal alterations in liver
that are the cause or a consequence of organ alteration or
dysfunction.
The aim of the present study is to develop a novel quantitative
imaging technique for trace metals and to characterize the
distribution of various metals in cryo-sections of normal, fibrotic
and cirrhotic human liver tissues. We demonstrate that most of the
metals analyzed are regularly distributed within normal liver
tissue, while they are redirected within fibrotic and cirrhotic livers
resulting in defined deposits suggesting that this method is not only
valuable in diagnosis of common metal disorders but also adequate
to determine subtle changes during ongoing liver fibrogenesis.
Materials and Methods
Patients and informed consent
Liver samples were taken from internal tissue banks of the
RWTH University Hospital Aachen or the University Hospital
Regensburg in which liver tissue was used for experimental
purposes that was acquired either from biopsies for routine clinical
purposes or explants of cirrhotic livers that were obtained during
liver transplantation. Each patient from which material is stored
provided written informed consent and the study was approved by
the local ethics committee at the RWTH Aachen University and
the University of Regensburg. Liver fibrosis/cirrhosis was diag-
nosed mainly on the grounds of liver routine histology. Fibrotic/
cirrhotic tissue samples used in this study were obtained from five
independent patients (D1 – D5). Secluded tissue from tumour-free
margins of resected hepatic metastasis within normal liver
parenchyma (N1 – N5) served as controls.
Immunohistochemical characterisation of liver
specimens
After being fixed in 4% buffered formalin for 24 h, the liver
tissue was embedded into paraffin wax. A histological semi-
quantitative examination of the liver was performed on sections
after standard Sirius Red and H & E stains. Liver sections were
stained with an anti-human a-SMA antibody using standard
procedures. To assess the degree of fibrosis, a standard Ladewig
staining was performed and the severity of liver biopsy lesions and
overall immunological activity were graded and staged according
to routine scoring guidelines of Desmet and Scheurer [19].
Patients with cirrhosis were stratified according to the Child-Pugh
score. The characteristics of the biopsies used in this study are
given in Table 1.
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Scanning Electron Microscopy with EDX analysis (SEM-
EDX)
Slices of 20 to 50 mm thickness were obtained from paraffin-
embedded liver tissue, sputtered with a conductive silver paint to
make contact on the surface, carbon-coated in a rotary evaporator,
and then maintained in desiccators to prevent air-contact before
analysis. Analysis of element content by EDX was rapidly
performed within two days of preparation using an environmental
scanning electron microscope (ESEM XL 30 FEG, FEI, PHILIPS,
Eindhoven, The Netherlands) in a high vacuum environment
operating at 15 to 20 kV. The slices were imaged by back-
scattered electrons and analysed for the elemental composition of
the element present. For quantitative analysis of the element
concretions, the contributions of the C-coating and the embedding
resin containing C, O and trace of Cl were computer-based
subtracted from the quantitative data of each spectrum.
Metal imaging of liver tissue section by laser ablation
inductively coupled plasma mass spectrometry (LA-ICP-
MS)
A quadrupole-based inductively coupled plasma mass spec-
trometer (ICP-MS, XSeries 2, Thermo Scientific, Bremen,
Germany) coupled to a laser ablation system (NWR 213, New
Wave Research, Fremont, CA, USA) was used to study elemental
distributions in tissue sections of human livers (30 mm thickness).
Laser ablation of biological tissue was performed using a focused
Nd:YAG laser beam in the scanning mode (wavelength 213 nm,
repetition frequency 20 Hz, laser spot diameter 60 mm, scanning
speed 60 mm s-1, laser fluency 0.24 J cm22). The ablated material
was transported by argon gas (as carrier gas) into the inductively
coupled plasma (ICP). The ions formed in the atmospheric
pressure ICP were extracted in the ultrahigh vacuum mass
spectrometer via a differential pumped interface, separated in the
quadrupole mass analyzer according to their mass-to-charge ratios
and detected by an ion detector. No reference standard materials
for quantification of metals in human liver were available.
Therefore, SRM NIST 1577b (bovine liver) was used as standard
reference material. The trace metal concentrations in the samples
were determined by single point calibration using this SRM.
Moreover, the selection of internal standard element is the
important part for LA-ICP-MS analyzing. The appropriate
internal standard element was chosen to correct for plasma
instabilities and sample-to-sample variations in the ion signal
intensity. In this work, sulphur was used as an internal standard
element for all the analyses because sulphur in human livers
present rather a homogeneous distribution and provide constant
concentration (see below). The human liver tissue and the NIST
standard reference material deposited on glass slide were mounted
in the laser ablation chamber to perform LA-ICP-MS imaging of
sample and standard reference material under identical experi-
mental conditions. Mass spectrometric measurements by LA-ICP-
MS for imaging of liver tissue were performed by line scanning
ablation (line by line) with a focused laser beam under the
optimized experimental parameters given in Table 2. The
experimental parameters of LA-ICP-MS were optimized with
respect to the maximum ion intensity of 63Cu+ using a SRM 1577b
Table 1. Characteristics of biopsy samples used in this study.
No. Internal Number / Origin Remarks / Desmet-Scheuer Score Etiology of disease
N1 NG237 / Aachen no fibrosis/ 0 liver metastasis from colon adenocarcinoma
N2 NG238 / Aachen no fibrosis/ 0 liver metastasis from breast adenocarcinoma
N3 NG265 / Aachen no fibrosis/ 0 hepatocellular carcinoma
N4 27 (normal) / Regensburg no fibrosis/ 0 no known disease history
N5 29 (normal) / Regensburg no fibrosis/ 0 slight signs of steatosis due to alcohol abuse
D1 NG205 / Aachen mild fibrosis, portal extracellular matrix
deposits/ 1
liver metastasis from colon adenocarcinoma; fibrosis of
unknown origin
D2 NG241 / Aachen cirrhosis/ 4 hepatocellular carcinoma; cirrhosis in chronic HCV
infection
D3 NG264 / Aachen cirrhosis/4 hepatocellular carcinoma; cirrhosis of unknown origin
D4 8 (cirrhosis) / Regensburg cirrhosis/ 4 cryptogenic cirrhosis, burned-out NASH
D5 23 (cirrhosis) / Regenburg cirrhosis/ 4 cryptogenic cirrhosis, burned-out NASH
doi:10.1371/journal.pone.0058702.t001
Table 2. Optimized experimental parameters used for LA-
ICP-MS imaging of human liver samples.
ICP mass spectrometer ICP-QMS, Thermo XSeries II
Rf power 1450 W
Cooling gas flow rate 16.0 L min-1
Auxiliary gas flow rate 0.7 L min-1
Carrier gas flow rate 1.0 L min-1
Dwell time 20 ms
Extraction lens potential 3400 V
Mass resolution (m/Dm) 300
Scanning mode peak hopping
Analysis time per liver sample
(10 mm610 mm)
4 hours
Laser ablation system New Wave (NRW213)
Wavelength of Nd:YAG laser 213 nm
Laser fluence 0.24 J cm-2
Repetition frequency 20 Hz
Laser spot size 60 mm
Scan speed 60 mm s-1
Ablation mode line scan
doi:10.1371/journal.pone.0058702.t002
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bovine liver standard. To validate the metal ion images, two isotopes
of the same element were analyzed, whenever possible. From the
continuous list of raw pixel values elemental images were reconstruct-
ed using the IMAGENA LA-ICP-MS Image Generation software
created at Forschungszentrum Juelich [20]. Trace metal concentra-
tions were calculated from ion intensities averaged throughout freely
drawn regions of interest (ROIs) within ion intensity images using
PMOD version 3.0 (details see www.pmod.com).
Results
Analysis of liver specimen by SEM-EDX
SEM-EDX is used for chemical analysis and determination of
the elemental composition of microscopic particles or regions
within a sample by in situ measuring the energy and intensity
distribution of X-ray signals generated by a focused electron beam
on the specimen (i.e. biopsy). It relies on the investigation of an
interaction of some source of X-ray excitation and the sample
resulting in a unique set of peaks on the X-ray spectrum that is
characteristic for each element. In brief, the necessary equipment
for this technique is based on an excitation source that transmits
an electron beam, an X-ray detector that converts X-ray energy
into voltage signals, a pulse processor and an analyzer that
processed the signals and matches them to individual atoms. Based
on the fact that this technique allows discriminating of metals, this
technique is used to corroborate or even score metal disorder in
organ tissue.
Figure 1. Representative SEM/EDX microanalysis in liver. (A) SEM overview of a paraffin embedded liver specimen from a patient (N1)
suffering from fibrosis. (B) The metal deposit that was subsequently analysed by EDX is marked by a white arrow. (C) Resulting elemental EDX
microanalyses of the marked mineral crust in (B). The peaks in the spectrum are labelled with the EDX line of the corresponding element.
doi:10.1371/journal.pone.0058702.g001
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When we applied this method to non-WD patients suffering
from liver fibrosis or cirrhosis, we noticed that although it allows
the identification of individual metal deposits (Figure 1), it was
unsuitable to discriminate between normal, fibrotic or cirrhotic
liver tissue. Moreover, the identification of metals by SEM-EDX is
somewhat critical because several elements have overlapping peaks
and data interpretation is somewhat enigmatic and only possibly
by highly experienced investigators.
LA-ICP-MS analysis of liver tissues
The introduction of LA-ICP-MS technology has recently been
successfully applied as a powerful imaging (mapping) technique to
produce quantitative images of detailed regionally specific element
distributions in thin tissue sections of human or rodent brain [21].
In an attempt to use this methodology for analysis of liver tissue,
we established a protocol that allows quantitative metal imaging of
liver tissue. In the final workflow, liver tissue is cryo-sected into
specimen of 30 mM thickness and mounted on glass slides (Figure
2B). Mass spectrometric measurements is then performed in the
LA-ICP-MS by line scanning ablation (line by line) with a focused
laser beam under the optimized experimental parameters given in
Table 1.
To evaluate the LA-ICP-MS imaging technique in liver
specimen and to further analyse if the concentration or
distribution of individual metals is altered in fibrotic or cirrhotic
liver tissue, we thought to apply this imaging technique in a small
set of histological well-characterized samples from normal, fibrotic
and cirrhotic liver tissue (Figure 3).
Trace metal imaging and quantification in selected liver
sections
The reproducibility of the LA-ICP-MS imaging technique for
the analysis of 20 mm thin cross section of human brain tissues is
already well studied [22]. 3% reproducibility had been observed
for homogeneous tissues (thin cross sections of matrix-matched
laboratory standards) and 5%–7% reproducibility for inhomoge-
neous tissue. Moreover, the applicability of LA-ICP-MS technique
was demonstrated in Parkinson mouse brain 14 mm sections
[23,24]. The reproducibility of 5% for Fe and Cu, 12% for Zn,
and 11% for Mn was presented. In our study, the replicate
Figure 2. Principle and workflow of LA-ICP-MS for hepatic metal imaging. (A) Principle and (B) Workflow of imaging mass spectrometry
from sample preparation of thin section by cryo-cutting, via the LA-ICP-MS measurement procedure by scanning of thin tissue section (line by line),
acquisition and evaluation of analytical data including quantification using single point calibration (NIST SRM 1577b bovine liver).
doi:10.1371/journal.pone.0058702.g002
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measurement of 4 adjacent sections of the same human liver tissue
(N3) were scanned using optimum condition of LA-ICP-MS in
order to determine the reproducibility (see Figure 4). The
reproducibility values calculated were 9% for S, 10% for Mn,
14% for Fe, 6% for Cu, 4% for Zn and Cd. Since sulphur is an
abundant element showing an overall homogenous distribution in
liver (see Figure 4, left panel), we used this non-metal as an internal
standard.
Figure 5 shows LA-ICP-MS images of the detected elements (C,
Na, Mg, P, K, Ca, Cr, Mn, Fe, Co, Cu, Zn, Mo, Ag, Cd, Sn, Hg,
and Pb) in a fibrotic liver sample (N3). Ca, Mn, Fe, Cu, Zn, Mo,
Cd, were detected with a higher abundance in fibrotic zones
compared to normal zones, whereas the ion intensity measured of
C, Na, Mg, P, K, Cr, Co, Ag, Sn, Hg, and Pb were not different
between fibrotic and normal zones. This picture presents the
potential of LA-ICP-MS to investigate the distribution of various
essential and toxic elements. However, no quantification of some
elements (C, P, Mo, Sn, and Hg) was possible due to the lack of
certified concentrations in the bovine liver standard reference
material used in this study.
Quantitative bioimages of Mn, Fe, Cu, Zn, and Cd of control
and diseased (fibrotic and cirrhotic) human liver samples are
illustrated in Figure 6 and Figure 7, respectively. In the case of
control liver samples, Mn, Cu, Zn, and Cd images are
homogeneous distributed. For Fe images, the hexagonal structure
was found clearly in N1 and N3 control liver sections. These
hexagonal shapes are corresponding to the structure of human
liver lobule and reflect the typical histological pattern of iron
deposition in the normal liver. As shown in the Fe image, Fe was
distributed predominantly around the rim of lobule structure. Fe
distribution presented a decreasing gradient from the rim area to
the central area. However, these hexagonal structures cannot be
investigated in disease liver tissue section (Figure 7).
The bioimaging approach of metals in fibrotic/cirrhotic liver
tissue sections by LA-ICP-MS revealed inhomogeneous distribu-
tion of Mn, Fe, Cu, Zn, and Cd. Very low concentrations of metals
were observed in fibrous septa areas when compared to nodules
areas. Moreover, the concentrations of Fe and Cu in all disease
liver (Figure 7) were significant higher than all control liver section
(Figure 6). In contrast, Zn concentrations in control liver samples
were higher than in disease liver. In comparison with the high Fe
content region (mark within circle area), it’s was found low
concentration of Cu (Figure 7).
Figure 8 compares the average of trace metal concentrations
measured in the control liver tissue (N1–N5) and disease liver
tissue (D1–D5). The average concentrations of Mn, Fe, Cu, Zn,
and Cd were 5.8, 493, 23, 140, and 1 mg g-1 in control; were 4.9,
576, 35, 80, and 0.5 in disease (fibrotic/cirrhotic) liver samples. In
the case of Mn and Cd, the different concentrations between
control and disease are not significant. On the other hand, the
concentration of Fe, Cu, and Zn are quite different between the
control and disease liver. Fe and Cu concentrations in diseased
liver are higher than in normal liver samples, while Zn
concentrations are decreased in diseased samples suggesting that
these changes can be used to predict the changing of liver state
from healthy to diseased liver.
Discussion
Hereditary liver diseases resulting in metal intoxication are
reasons for morbidity and mortality worldwide [25,26]. In
addition, various liver diseases including both alcoholic and non-
alcoholic steatohepatitis are associated with increased iron deposits
[27,28]. Furthermore several trace elements are known to
influence the outcome of hepatitis virus infections [29]. Although
there have been great advancements in the establishment of novel
genetic test systems and measurements of serum parameters that
are indicative and suitable for identification of respective diseases
or intoxications, metal stains in liver sections and other techniques
like SEM-EDX measurements are traditionally the confirmatory
diagnostic tests for hepatic metal poisoning and is one the first
sight attractive because (i) the detectors have high sensitivity due to
a wide solid angle collecting the X-rays emitted from the sample,
(ii) the entire chemical composition of the analyzed specimen can
be observed without wavelength scans, and (iii) analysis time are
rather small [30]. However, the accuracy of techniques that are
based on electron-microscopic analysis of liver sections such as
SEM-EDX is limited by several factors. First the analysts
performing the SEM have a bias and restrict their analysis to
material deposits that are visible. Second several elements in EDX
have overlapping peaks that under certain constellations does
prevent precise assignment of signals to element. Third quantifi-
cation of individual element concentration is impossible or only
hardly to achieve. Finally, the accuracy of the spectrum can also be
affected by the nature of the sample per se in that way that
inhomogeneous samples result in inadequate or dissimilar
excitations.
X-rays can be generated by any atom in the sample that is
sufficiently excited by the incoming beam. These X-rays are
emitted in any direction, and so they may not all escape the
sample. The likelihood of an X-ray escaping the specimen, and
thus being available to detect and measure depends on the energy
of the X-ray and the amount and density of material it has to pass
Figure 3. Representative immunohistochemical analysis of
liver sections of patients enrolled in this study. (A, C, E) Normal
(N1) and (B, D, F) cirrhotic liver tissues (D2) were stained with (A, B)
hematoxylin and eosin, (C, D) Ladewig, or (E, F) probed with an
antibody specific for a-SMA. The space bar in each figure represents
100 mM each.
doi:10.1371/journal.pone.0058702.g003
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through. This can result in reduced accuracy in inhomogeneous
and rough samples.
All these limitations of SEM-EDX measurements become
evident in our experiment that is depicted in Figure 1 demon-
strating that this method is not sensitive enough to illustrate trace
metal distribution or even quantify individual metals in the
analyzed liver specimens.
LA-ICP-MS on the other side is one of the most powerful and
sensitive techniques for the analysis of a variety of solid samples
because it provides good sensitivity for major, minor, trace, and
ultra-trace elements with high sample throughput and without
sample preparation which generates a large amount of waste as
occurring in solution-based techniques [14]. Several years ago, the
imaging analysis for biometal concentrations in human tissues
obtained either by biopsy or postmortem was becoming an
increasingly important function of the clinical laboratory.
The use of matrix matched reference material for quantification
of analytical data is important because the ablation yield varies
with the sample matrix. However, an appropriate matrix-matched
standard reference material that for metal in human liver is not
available. The most common quantification method for tissue in
LA-ICP-MS is external calibration utilizing matrix-matched
standards [24]. In the ongoing project, suitable matrix-matched
tissue standards with well-defined concentrations of the biometals
of interest were created and used for the calibration of the LA-
ICP-MS technique. Several independent other studies have shown
Figure 4. Reproducibility of imaging of elements in liver tissue sample. Representative spatial distribution of elements of interest (S, Mn, Fe,
Cu, Zn, and Cd) in four adjacent sections from the same human liver tissue is depicted.
doi:10.1371/journal.pone.0058702.g004
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that this one point calibration method also known as offset-only
calibration gives a reasonable accuracy in quantification of various
metals in LA-ICP-MS [12,17,31,32].
Human liver consists of two main lobes, left and right, which
overlap slightly. Each lobe contains lobules that are the building
blocks of the liver that are six-sided structures or hexagonal shapes.
As shown in Figure 6, Fe-rich regions are found around the rim of
hexagonal shape. In contrast, the concentrations of Fe become
lower at the central of structure. Our results also support the
previous finding, which investigated the distribution of Fe in liver
tissue. Kinoshita and coworkers have been reported distribution in
the lobule of human liver by synchrotron radiation X-ray
fluorescence (SRXRF) microscopy [33]. In their report, Fe was
distributed predominantly in periportal hepatocytes in the normal
liver in a decreasing gradient from the periportal area (rim of
hepatocyte) to the perivenous area (central of hepatocyte).
Mn is one of the important trace biometal, which can be
detected in human liver. Mn is secreted in bile and concentration
increase in cholestatic liver disease. The manganese content of the
liver is very high as compared to its concentration in serum [34]. It
has also been demonstrated that the liver has an important role in
the excretion of manganese. Previous findings reported the
increasing of whole blood Mn concentrations in patients with
liver cirrhosis [35,36]. Moreover, they suggested that in cirrhosis of
the liver failure of biliary excretion of Mn leads to overload and
subsequent cerebral accumulation of this metal. Mn accumulates
in mitochondria, a major source of superoxide, which can oxidize
Mn2+ to the powerful oxidizing agent Mn3+ [37]. Oxidation of
important cell components by Mn3+ has been suggested as a cause
of the toxic effects of it. For our results, in fibrotic/cirrhotic tissue
samples (Figure 7), Mn was increased to higher concentration in
fibrotic and cirrhotic zones compared to non-tumor zones.
Figure 5. LA-ICP-MS imaging of essential and toxic metals and carbon in hepatic cirrhosis. Representative LA-ICP-MS maps of C, Na, Mg,
P, K, Ca, Cr, Mn, Fe, Co, Cu, Zn, Mo, Ag, Cd, Sn, Hg, and Pb isotope as detected in cirrhotic human liver sample (D3).
doi:10.1371/journal.pone.0058702.g005
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However, the average concentrations of Mn in control liver and
disease samples (Figure 8) are not significant different.
In the animal model of liver fibrogenesis, iron acts as a ‘‘co-
factor’’ of fibrogenesis [38]. Within the liver, iron related oxidative
stress can lead to fibrosis and ultimately to cirrhosis [39]. When
present in excess within the cell (hemochromatosis), iron can be
toxic due to its ability to catalyze the formation of damaging
radicals via a chemical reaction known as the Fenton reaction,
which promote cellular injury and cell death. The results shown in
this study could be in agreement with results from previous studies.
In the control livers, the distributions of Fe are quite homoge-
neous. In contrast to disease livers, higher concentration of Fe was
found in fibrotic or cirrhotic area when compared to normal area.
For fibrotic liver, Fe concentration is higher than control tissue
(Figure 8). However, the different between these values are not
significant. In contrast to fibrotic tissue, the average concentrations
of Fe in cirrhotic liver samples are higher than control liver about
three times.
Not only Fe overload, the accumulation of too much Cu in WD
is able to catalyze the development of liver disease. The major
physiologic aberration is excessive absorption of copper from the
small intestine and decreased excretion of copper by the liver. WD
is an inherited metabolic disorder characterized by accumulation
of copper in the tissue leading to progressive hepatic damage in the
Figure 6. Selected LA-ICP-MS images in control liver samples. Images of Mn, Fe, Cu, Zn and Cd of control human liver samples (N1-N5)
measured by LA-ICP-MS.
doi:10.1371/journal.pone.0058702.g006
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liver and the other organs [40,41]. With progressive parenchymal
damage, fibrosis and subsequently cirrhosis can be developed. In
early stages of the disease, copper is mainly in the cytoplasm
bound to metallothionein and is not histochemically detectable; in
later stages, copper is found predominantly in lysosomes [41]. The
amount of copper varies from nodule to nodule in cirrhotic liver
and may vary from cell to cell in pre-cirrhotic stages. The absence
of histochemically identifiable copper does not exclude WD, and
this test has a poor predictive value for screening for WD. By use
of LA-ICP-MS, we found inhomogeneous distributions in all
fibrotic/cirrhotic liver sections analyzed. The average concentra-
tions of fibrotic and cirrhotic are 204, and 210 mg g-1, and 39.4 mg
g-1 for control tissue samples. With these data, Cu is the important
element that relates to the stage of liver failure and therefore used
as an indicator for liver damage.
Zn is necessary for normal liver function and, the liver plays a
central role in Zn homeostasis [42,43]. The liver is important for
the regulation of zinc homeostasis, while zinc is necessary for
proper liver function. It has long been speculated that Zn has a
protective effect against liver fibrosis [42,44]. In our study, Zn
concentrations in liver tissue were decreased from control (319 mg
g-1), fibrosis (223 mg g-1), and cirrhosis (192 mg g-1), respectively.
Data obtained from our and previous studies suggest that ongoing
liver disease correlates with reduced Zn levels. These findings fit
Figure 7. Selected LA-ICP-MS images in diseased liver. Images of Mn, Fe, Cu, Zn and Cd of fibrotic (D1) and cirrhotic human liver samples (D2-
D5) measured by LA-ICP-MS.
doi:10.1371/journal.pone.0058702.g007
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quite well with recent experimental observations showing that Fe
and Cu act in an antagonistic fashion and iron is an important
factor triggering copper deficiency in liver [45].
Cadmium is a highly toxic element present in food and water. It
can deposit in the liver and kidney and strongly binds to
macromolecules in the intracellular compartment and influences
the metabolism of Fe, Ca, Zn, Mn and Cu [46,47]. Therefore, the
overloading of Cd in liver may be disturbed the protective function
of Zn to liver disease. However, Cd concentrations of control
samples in our study are slightly higher than in fibrotic and
cirrhotic samples. This result may be due to the fact that Cd
concentration in liver tissue varies depending on many factors.
The major route for cadmium intake for non-smoker is ingestion
of cadmium in foodstuffs of natural origin or from the use of
phosphate fertilizers and sludge on agricultural soils. Smokers have
elevated blood and tissue concentrations of cadmium from
cigarette smoke. As shown in Figure 8, the average concentration
of the toxic trace metal Cd is not higher than 1 mg g-1 in all tissue
samples.
Considering all known hepatic diseases that are caused,
promoted or modulated by accumulation of metals, there is a
mandatory need for the establishment and evaluation of precise
non-invasive metal imaging methods for diagnostics. In recent
years, many studies have demonstrated the possibility of perform-
ing hepatic iron quantification with magnetic resonance imaging
technology. However, a consensus has not been reached yet
regarding the technique or the possibility to reproduce the same
method of calculus in different equipments and intensive
discussion for the establishment of consensus guidelines for clinical
practice of hepatic iron quantification by magnetic resonance
imaging techniques are conducted [48]. Since recent experimental
and clinical studies have further demonstrated that different metals
act as strong modifiers that influence the outcome of hepatic
fibrogenesis [10,49], it is obvious that the quantitative trace metal
determination in the diagnosis of disease progression will
potentially become more important in future. The demonstration
that LA-ICP-MS imaging representing one direct solid sampling
technique for major, minor and trace element analysis is suitable
for biometal analysis in normal and disease liver will therefore
enrich the spectrum of diagnostic options. It allows to parallel
measure the metal content in cryo-sections that become available
in routine biopsy that still represent the gold standard for accurate
assessment of the degree of fibrosis or presence of cirrhosis.
It would be an absolute goal to further analyze the sub-lobular
and sub-cellular distribution of signals regarding different metals in
both normal and disease conditions. In our study we noticed that
the signals of several metals are more punctuated than others.
However, the precise mapping of individual metals to cellular
subpopulation of the liver is a complex venture and must be
addressed in future studies. There are however already pioneering
studies available that have already precisely co-localized aggre-
gates and mercury deposits within cellular subpopulations of the
liver [50]. Such studies would be fundamental for understanding
the pathophysiological relevance of individual hepatic cells
including Kupffer cells, hepatocytes, sinusoidal endothelial cells,
hepatic stellate cells, and Pit cells (or even hepatic stem cells) in any
kind of metal-induced liver disorders.
In summary, all these findings indicate that LA-ICP-MS is a
novel powerful and innovative analytical technique that will have
tremendous impact on diagnostics of metal disorders in liver. The
fact that the obtained metal concentrations in liver tissue were the
same in specimen that were obtained from two different hospitals
(Aachen and Regensburg) further demonstrates that the results
obtained in LA-ICP-MS are mostly independent from potential
pre-analytical differences that may arise from sample collection.
Although we presently do not know how individual hepatic
disorders impact the distribution and location of individual metals
or groups, it is known that metal overload or lack of individual
metals may induce or contribute to the pathogenesis of liver
disease. Therefore, LA-ICP-MS allowing quasi-simultaneous
measurement of all metals and selected non-metals will provide
an important add-on to routine diagnosis of liver sections or
biopsies.
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